Halbert Hargrove Global Advisors LLC purchased a new position in The Clorox Company (NYSE:CLX – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 220 shares of the company’s stock, valued at approximately $36,000.
Other institutional investors have also modified their holdings of the company. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after acquiring an additional 95 shares in the last quarter. Prospera Private Wealth LLC acquired a new position in shares of Clorox in the third quarter worth about $27,000. Continuum Advisory LLC increased its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc bought a new stake in Clorox in the fourth quarter valued at about $32,000. Finally, BankPlus Trust Department bought a new stake in Clorox in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on the company. JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Finally, TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $159.62.
Clorox Stock Performance
Shares of CLX stock opened at $156.52 on Friday. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The firm has a market capitalization of $19.28 billion, a price-to-earnings ratio of 42.76, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The business has a 50 day simple moving average of $156.88 and a 200 day simple moving average of $160.26. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period last year, the business posted $2.16 earnings per share. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.
Clorox Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.12%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio (DPR) is 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is the Australian Securities Exchange (ASX)
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Energy and Oil Stocks Explained
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Overbought Stocks Explained: Should You Trade Them?
- MarketBeat Week in Review – 02/24 – 02/28
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.